newsfilter
← Latest News
PR Newswire·

Scinai Expands CDMO Business with $5.1 Million Development and Clinical Manufacturing Agreement

Committed Customer Orders¹ reach approximately $7.6 million, up approximately 300% from $1.9 million at year-end 2025Agreement with a U.S. based, Nasdaq-listed biopharmaceutical company supports development activity in